• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effects of meal on the pharmacokinetics of fluoride from oral monofluorophosphate.

作者信息

Warneke G, Setnikar I

机构信息

Zentrum Innere Medizin, Medizinische Klinik und Poliklinik, Georg August Universität, Göttingen, Fed. Rep. of Germany.

出版信息

Arzneimittelforschung. 1993 May;43(5):590-5.

PMID:8329005
Abstract

A two-treatment cross-over study was conducted on 8 Caucasian male healthy volunteers aged between 26 and 32 years in order to determine the influence of a standard meal on the bioavailability and pharmacokinetics of fluoride after a single oral administration of tablets containing the equivalent of 10 mg fluoride as sodium monofluorophosphate (Na-MFP, CAS 10163-15-2) in a fixed combination with 300 mg Ca as calcium gluconate and calcium citrate. The meal provoked a significant delay of the appearance of fluoride in blood (from 4 to 11 min), a slowing of the absorption rate, a prolongation of tmax (from 34 to 146 min), a decrease of Cmax (from 369 to 122 ng/ml) and a prolongation of the Mean Residence Time (from 7.1 to 9.1 h). However, the amount of fluoride entering in the systemic circulation was not affected by the meal, as shown by the ANOVA on the AUC and on the cumulated urinary excretion of fluoride in the 48 h following the administration of Na-MFP. It is concluded that appropriate meals do not influence the amount of absorbed fluoride from Na-MFP, and that they modify the rate of absorption with pattern that may improve the safety and possibly also the efficacy of Na-MFP.

摘要

相似文献

1
Effects of meal on the pharmacokinetics of fluoride from oral monofluorophosphate.
Arzneimittelforschung. 1993 May;43(5):590-5.
2
Bioavailability and pharmacokinetics of fluoride from two glutamine monofluorophosphate preparations.两种谷氨酰胺单氟磷酸制剂中氟的生物利用度和药代动力学
Arzneimittelforschung. 1993 May;43(5):584-90.
3
Relative bioavailability of fluoride from monofluorophosphate tablets after single oral administration.
Arzneimittelforschung. 1990 Mar;40(3):323-8.
4
Bioequivalence of sodium monofluorophosphate with sodium fluoride and compatibility with calcium.
Arzneimittelforschung. 1990 Sep;40(9):994-9.
5
Bioavailability and pharmacokinetic characteristics of two monofluorophosphate preparations with calcium supplement.
Arzneimittelforschung. 1998 Dec;48(12):1172-8.
6
Bioavailability of fluoride administered as sodium fluoride or sodium monofluorophosphate to human volunteers.
Arzneimittelforschung. 1996 May;46(5):531-3.
7
Absolute bioavailability of fluoride from disodium monofluorophosphate and enteric-coated sodium fluoride tablets.来自单氟磷酸二钠和肠溶包衣氟化钠片剂的氟化物的绝对生物利用度。
Eur J Clin Pharmacol. 1996;50(4):321-6. doi: 10.1007/s002280050116.
8
Influence of food on relative bioavailability of fluoride in man from Na2FPO3-containing tablets for the treatment of osteoporosis.食物对用于治疗骨质疏松症的含Na2FPO3片剂中氟在人体相对生物利用度的影响。
Int J Clin Pharmacol Ther Toxicol. 1989 May;27(5):242-9.
9
[Comparison of the fluoride bioavailability from two oral preparations of monofluorophosphate disodium in combination with various calcium salts].[两种磷酸二氢钠口服制剂与多种钙盐联合使用时氟生物利用度的比较]
Therapie. 1990 May-Jun;45(3):235-41.
10
Pharmacokinetic differences between sodium fluoride and sodium monofluorophosphate and comparative bone mass increasing activity of both compounds in the rat.
Arzneimittelforschung. 1994 Jun;44(6):762-6.

引用本文的文献

1
The use of urinary fluoride excretion to facilitate monitoring fluoride intake: A systematic scoping review.利用尿氟排泄来促进氟化物摄入量监测:系统范围界定审查。
PLoS One. 2019 Sep 11;14(9):e0222260. doi: 10.1371/journal.pone.0222260. eCollection 2019.
2
Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study.依替膦酸二钠与序贯单氟磷酸钠治疗重度绝经后骨质疏松症的疗效:一项初步研究。
Rheumatol Int. 2005 May;25(4):296-300. doi: 10.1007/s00296-004-0570-x. Epub 2005 Mar 16.
3
Treatment of postmenopausal vertebral osteopenia with monofluorophospate: a long-term calcium-controlled study.
单氟磷酸酯治疗绝经后椎体骨质减少:一项长期钙对照研究。
Osteoporos Int. 1995;5(6):467-71. doi: 10.1007/BF01626610.
4
What is the future for fluoride in the treatment of osteoporosis?氟化物在骨质疏松症治疗中的未来发展前景如何?
Osteoporos Int. 1995 Mar;5(2):71-4. doi: 10.1007/BF01623306.